BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2020
View Archived Issues
Zebrafish embryos xenografted with ACC cells to study antitumor effects of abiraterone acetate
Read More
Noncoding RNA protects blood vessel walls
Read More
Glutaminase 1 is NASH target
Read More
Sojournix begins phase II study of SJX-653 for vasomotor symptoms due to menopause
Read More
FDA approves Fluad Quadrivalent influenza vaccine for use in adults age 65 years and older
Read More
Phase II results for olaparib with or without cediranib in mCRPC
Read More
Novel homeostatic lipid mediators show neuroprotection in rat model of cerebral ischemia
Read More
ASOs targeting GYS1 show promise in mouse model of Pompe disease
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group patents boric acid derivatives
Read More
Blue Sky Pharmaceuticals describes new mu-opioid receptor agonists for pain
Read More
GlaxoSmithKline and ViiV Healthcare present compounds for HIV infection
Read More
Guangzhou Henovcom Bioscience identifies new NR1H4 agonists
Read More
siRNA reduction of HBV antigens increases vaccine efficacy in persistent mice HBV infections
Read More
New USP28 and USP25 inhibitors presented by FORMA Therapeutics
Read More
Herantis reports topline data from phase I/II study of CDNF in Parkinson's disease
Read More
Bluebird bio presents phase I/II data on LentiGlobin for sickle cell disease
Read More
COVID-19 spreading but not yet pandemic disease, says WHO
Read More
Moderna releases novel coronavirus vaccine mRNA-1273 to NIAID for phase I trial
Read More
Phase II study of IO-102 in NSCLC cleared to continue following futility analysis
Read More
Ascentage cleared to begin phase Ib/II trial in China with APG-1387 for pancreatic cancer
Read More
Affimed studies AFM-24 in phase I/II study for advanced solid tumors
Read More
